LANDSCAPE: An FNCLCC phase II study with lapatinib (L) and capecitabine (C) in patients with brain metastases (BM) from HER2-positive (+) metastatic breast cancer (MBC) before whole-brain radiotherapy (WBR).
暂无分享,去创建一个
M. Campone | G. Romieu | J. Pierga | V. Diéras | M. Gutiérrez | T. Bachelot | J. Ferrero | É. Le Rhun | A. Gonçalves | M. Jimenez | H. Curé | C. Labbé | M. Leheurteur | H. Roché | J. Dômont | C. Cropet | E. Rhun | M. Campone | Maya Gutierrez | H. Curé | J. Ferrero | J-Y Pierga | Véronique Diéras | G. Romieu